跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
2-Se-Cl
首页
药物
2-Se-Cl
2-Se-Cl
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Polymerization regulators and compositions for resin
US 7169845 B2
申请人: MITSUBISHI GAS CHEMICAL CO
优先权: 2001
US
4 件公开
Treatment of bipolar disorder
US 8901158 B2
申请人: CHURCHILL GRANT C
优先权: 2011
US
2 件公开
Method of producing 1-hydroxy-1,1-diphosphonic acid compounds
US 2004087554 A1
申请人: BLUM HELMUT
优先权: 2001
US
Substituted Pyrido¬3',2':4,5 thieno¬3,2-d pyrimidin-2,4(1H,3H)diones and -4(3H)ones as well as Pyrido¬3',2':4,5 furo¬3,2-d -pyrimidin-2,4(1H,3H)diones und -4(3H)ones as inhibitors of TNF-alpha release
EP 1619197 A1
申请人: CURACYTE DISCOVERY GMBH
优先权: 2004
EP
3-Amino-6-aryl(or 6-heteroaryl)-thieno¬2,3-b pyridin-2-carboxylic acid amides, pharmaceutical compositions comprising the said and their use as inhibitors of TNFalpha release
EP 1681292 A1
申请人: IBFB PHARMA GMBH
优先权: 2005
EP
Method for regioselective synthesis of 1-alkyl-3-haloalkyl-1-pyrazol-4-carbonic acid derivatives
EP 2100883 A1
申请人: BAYER CROPSCIENCE AG
优先权: 2008
EP
Onium salts and their use for detecting and dosing metals
EP 2112138 A1
申请人: COMMISSARIAT ENERGIE ATOMIQUE
优先权: 2008
EP
Organic semiconductor material and thin-film transistor
CN 103627147 A
申请人: AU OPTRONICS CORP
优先权: 2013
CN
Production and use of zinc amides
US 9688701 B2
申请人: UNIV MUENCHEN LUDWIG MAXIMILIANS
优先权: 2016
US
Treatment of unipolar depressive disorder
US 11707453 B2
申请人: UNIV OXFORD INNOVATION LTD
优先权: 2017
US
第 1 / 2 页
上一页
下一页
药物
反馈